Parametrica Management Portfolio holdings

Parametrica Management's Q1 2016 Portfolio in Review

As of Q1 2016, Parametrica Management held 150 positions worth $27.9M, up 84% from $15.2M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Parametrica Management deployed $12.2M of net new capital in Q1 2016, opening 90 new positions and adding to 7 existing holdings. Its largest new stake was Insys Therapeutics, Inc.: 33,562 shares worth $537K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Finisar Corp, an estimated $315K trimmed.

• Parametrica Management's largest Q1 2016 buy was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
• Parametrica Management added most to CNH Industrial in Q1 2016, an estimated $424K increase.
• Parametrica Management's biggest Q1 2016 reduction was Finisar Corp, cutting an estimated $315K.
• Parametrica Management fully exited PTC Therapeutics in Q1 2016, selling an estimated $519K.
• Parametrica Management's ten largest holdings make up 18% of its $27.9M portfolio in Q1 2016.
• Parametrica Management opened 90 new positions and closed 47 in Q1 2016.
• Parametrica Management's portfolio value rose 84% quarter-over-quarter to $27.9M.

Based on Parametrica Management's 13F filing for Q1 2016, filed 5 May 2016.